
Solid IO has been selected among the most promising European deep tech startups in biotech to present at European DeepTech Week in Paris in March 2026.
CEO and co-founder Noora Hujala will present Solid IO’s vision to sector-specific VCs, CVCs and angel investors in the Women in Biotech session at the InvestEU Portal DeepTech Forum, part of the official European DeepTech Week programme.
European DeepTech Week brings together founders, investors, policymakers and industry leaders shaping the future of European innovation. The Women in Biotech session highlights leading female-founded companies advancing scientific and technological breakthroughs in biotech.
Solid IO looks forward to engaging with stakeholders across the European deep tech and life sciences ecosystem.

Join us in transforming cancer care with groundbreaking organ-on-chip technology. We’re calling on researchers, clinicians, and investors to partner with us in advancing precision medicine, accelerating innovation, and expanding global access to personalized oncology. Together, we can bring clarity and better outcomes to cancer care worldwide.